Abiopharma

🔍 Carter David M (Executive)

Company: KRATOS DEFENSE & SECURITY SOLUTIONS, INC. (KTOS)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Sold 1,300 shares of Common Stock at $56.8531 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 76,771.00 | transaction_form_type: 4 | Footnotes: F1, F2, F6
• Sold 1,300 shares of Common Stock at $57.9831 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 75,471.00 | transaction_form_type: 4 | Footnotes: F1, F3, F6
• Sold 1,100 shares of Common Stock at $58.7391 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 74,371.00 | transaction_form_type: 4 | Footnotes: F1, F4, F6
• Sold 200 shares of Common Stock at $59.99 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 74,171.00 | transaction_form_type: 4 | Footnotes: F1, F5, F6
• Sold 100 shares of Common Stock at $61.05 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 74,071.00 | transaction_form_type: 4 | Footnotes: F1, F6

Footnotes:

• F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on June 13, 2025.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.51 to $57.33 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.54 to $58.52 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.57 to $59.01 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.87 to $60.11 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
• F6: Includes 12,200 shares purchased through Issuer's Employee Stock Purchase Plan and 4,165 shares held through reporting person's retirement account; and approximately 138 shares held through Issuer's 401(k) Plan.